{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:06:34Z","timestamp":1753182394982},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10384-011-0087-2","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T03:50:21Z","timestamp":1315453821000},"page":"625-631","source":"Crossref","is-referenced-by-count":10,"title":["Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion"],"prefix":"10.1007","volume":"55","author":[{"given":"Atsushi","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Mitarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"87_CR1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/B978-0-323-02598-0.50077-X","volume-title":"Retina","author":"S Phillips","year":"2006","unstructured":"Phillips S, Fekrat S, Finkelstein D. Branch retinal vein occlusion. In: Ryan SJ, editor. Retina. 4th edn. Philadelphia: Elsevier Inc; 2006. p. 1349\u201354.","edition":"4"},{"key":"87_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","volume":"33","author":"J Rehak","year":"2008","unstructured":"Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res. 2008;33:111\u201331.","journal-title":"Curr Eye Res"},{"key":"87_CR3","first-page":"488","volume":"83","author":"FA Gutman","year":"1977","unstructured":"Gutman FA. Macular edema in branch retinal vein occlusion: prognosis and management. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83:488\u201395.","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"87_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","volume":"98","author":"The Branch Vein Occlusion Study Group","year":"1984","unstructured":"The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271\u201382.","journal-title":"Am J Ophthalmol"},{"key":"87_CR5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s004170050339","volume":"237","author":"MB Parodi","year":"1999","unstructured":"Parodi MB, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 1999;237:1024\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"87_CR6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"The SCORE Study Research Group","year":"2009","unstructured":"The SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion. Arch Ophthalmol. 2009;127:1115\u201328.","journal-title":"Arch Ophthalmol"},{"key":"87_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/IAE.0b013e318195ca65","volume":"29","author":"V Russo","year":"2009","unstructured":"Russo V, Barone A, Conte E, Prascina F, Stella A, Noci ND. Bevacizumab compared with macular laser grid photocoagulation for cystoids macular edema in branch retinal vein occlusion. Retina. 2009;29:511\u20135.","journal-title":"Retina"},{"key":"87_CR8","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/IAE.0b013e3181aa8e20","volume":"29","author":"M Kondo","year":"2009","unstructured":"Kondo M, Kondo N, Ito Y, Kachi S, Kikuchi M, Yasuma TR, et al. Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12\u00a0months and multiple regression analysis. Retina. 2009;29:1242\u20138.","journal-title":"Retina"},{"key":"87_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00417-008-0916-2","volume":"247","author":"G Jaissle","year":"2009","unstructured":"Jaissle G, Leitritz M, Gelisken F, Zimssen F, Bartz-Schmidt KU, Szuman P. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2009;247:27\u201333.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"87_CR10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/IAE.0b013e3181bcef53","volume":"29","author":"L Wu","year":"2009","unstructured":"Wu L, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Canton V, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusion. Retina. 2009;29:1396\u2013403.","journal-title":"Retina"},{"key":"87_CR11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bjo.2009.173732","volume":"94","author":"MS Figueroa","year":"2010","unstructured":"Figueroa MS, Contreras I, Noval S, Arruabarrena C. Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol. 2010;94:1052\u20136.","journal-title":"Br J Ophthalmol"},{"key":"87_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3:391\u2013400.","journal-title":"Nat Rev Drug Discov"},{"key":"87_CR13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","volume":"140","author":"H Noma","year":"2005","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256\u201361.","journal-title":"Am J Ophthalmol"},{"key":"87_CR14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.09-4140","volume":"51","author":"T Miyake","year":"2010","unstructured":"Miyake T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ogasawara K, et al. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes. Invest Ophthalmol Vis Sci. 2010;51:1606\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"87_CR15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00417-009-1167-6","volume":"248","author":"T Ach","year":"2010","unstructured":"Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S. Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248:155\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"87_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0420.2001.790502.x","volume":"79","author":"E Stefansson","year":"2001","unstructured":"Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand. 2001;79:435\u201340.","journal-title":"Acta Ophthalmol Scand"},{"key":"87_CR17","first-page":"877","volume":"41","author":"A Arnarsson","year":"2000","unstructured":"Arnarsson A, Stefansson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2000;41:877\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"87_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1002499920673","volume":"97","author":"F Bandello","year":"1999","unstructured":"Bandello F, Lanzetta P, Menchini U. When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol. 1999;97:415\u20139.","journal-title":"Doc Ophthalmol"},{"key":"87_CR19","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2009.09.019","volume":"117","author":"PS Prasad","year":"2010","unstructured":"Prasad PS, Oliver SCN, Coffee RE, Hubschman JP, Schwartz SD. Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology. 2010;117:780\u20134.","journal-title":"Ophthalmology"},{"key":"87_CR20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","volume":"117","author":"JA Haller","year":"2010","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, OZURDEX GENEVA Study Group, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134\u201346.","journal-title":"Ophthalmology"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-011-0087-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-011-0087-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-011-0087-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:20:33Z","timestamp":1559132433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-011-0087-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s10384-011-0087-2","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}